KALA Kala Pharmaceuticals Inc.

Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.

$1.82  +0.09 (5.20%)
As of 12/02/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/20/2017
Outstanding shares:  65,500,275
Average volume:  1,581,103
Market cap:   $113,315,476
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    483119103
ISIN:        US4831191030
Sedol:      BF2F1K4
Valuation   (See tab for details)
PE ratio:   -0.95
PB ratio:   1.93
PS ratio:   9.75
Return on equity:   -205.22%
Net income %:   -1,085.43%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy